SERPINA1 and COVID-19: Thus, α1AT may serve as natural inhibitor of the novel coronavirus, in particular during acute SARS-CoV-2 infection, when blood α1AT concentrations increase, as recently shown in a cohort of 40 COVID-19 patients27.